Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 575 of 984 entries
View as:

Specified Drug-Use Survey on Vedolizumab for IV Infusion 300 mg [Crohn's Disease]

Phase: N/A Priority: Normal
NCT ID: NCT04002180 Org: User:
Start: 07/01/19 End: 10/31/25 Due: 10/31/26

Efficacy and Safety Study of TAK-559 in Treating Subjects With Type 2 Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT00762684 Org: User:
Start: 11/30/04 End: 12/31/04 Due: 12/31/05

International Multicenter, Observational, Non-Interventional Prospective Study of Azilsartan Medoxomil in Participants With Arterial Hypertension Who Are Overweight or Obese in the Russian Federation and The Republic of Kazakhstan

Phase: N/A Priority: Normal
NCT ID: NCT02756819 Org: User:
Start: 07/18/16 End: 05/08/18 Due: 05/08/19

Study of Efficacy of Ramelteon in Adults With Chronic Insomnia

Phase: N/A Priority: Normal
NCT ID: NCT00671125 Org: User:
Start: 01/31/03 End: 09/30/03 Due: 09/30/04

A Study to Observe the Safety and Efficacy of Vedolizumab in Biologically Naive Participants With Ulcerative Colitis (UC) or Crohn´s Disease (CD)

Phase: N/A Priority: Normal
NCT ID: NCT02986724 Org: User:
Start: 01/04/17 End: 08/31/20 Due: 08/31/21

Alogliptin/Pioglitazone (Liovel) Combination Tablets Survey on Long-term Use in Patients With Type 2 Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT01990300 Org: User:
Start: 11/28/11 End: 03/31/15 Due: 03/31/16

Ramelteon 8 mg Tablets Specified Drug-use Survey: <Long-term Survey on Insomnia Accompanied by Difficulty Falling Asleep> - Transitional Survey From the Preceding Drug-use Survey -

Phase: N/A Priority: Normal
NCT ID: NCT02153086 Org: User:
Start: 03/31/11 End: 06/30/14 Due: 06/30/15

A Study on Cytomegalovirus (CMV) Infection Outcomes Among Hematopoietic Stem Cell Transplant (HSCT) Participants in Europe and Canada

Phase: N/A Priority: Normal
NCT ID: NCT05571137 Org: User:
Start: 05/31/23 End: 01/31/24 Due: 01/31/25

A Survey of Maribavir Tablets in Participants with Cytomegalovirus Infection

Phase: N/A Priority: Normal
NCT ID: NCT06577363 Org: User:
Start: 08/28/24 End: 08/30/31 Due: 08/30/32

A Study of Brigatinib as Preferred First Therapy for Adults With Non-Small Cell Lung Cancer (NSCLC) ENTIRETY

Phase: N/A Priority: Normal
NCT ID: NCT05735327 Org: User:
Start: 05/22/23 End: 06/01/27 Due: 06/01/28

Study of Alogliptin Combined With Sulfonylurea in Subjects With Type 2 Diabetes Mellitus.

Phase: N/A Priority: Normal
NCT ID: NCT00286468 Org: User:
Start: 04/30/06 End: 06/30/07 Due: 06/30/08

Study of Relationship Between Vedolizumab Therapeutic Drug Monitoring, Biomarkers of Inflammation and Clinical Outcomes

Phase: N/A Priority: Normal
NCT ID: NCT04567628 Org: User:
Start: 10/05/20 End: 09/22/21 Due: 09/22/22

A Study of Brentuximab Vedotin Treatment in Chinese Adults With CD30-Positive Cutaneous T-Cell Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT05442554 Org: User:
Start: 07/20/23 End: 08/09/24 Due: 08/09/25

A Spanish Medical Record Review of Adults With Relapsed or Refractory CD30+ Malignancies When Re-treated With Brentuximab-vedotin

Phase: N/A Priority: Normal
NCT ID: NCT04998331 Org: User:
Start: 10/29/21 End: 09/07/23 Due: 09/07/24

A Study of Freeze-dried Human Protein C Concentrate (TAK-662) in Participants with Congenital Protein C Deficiency

Phase: N/A Priority: Normal
NCT ID: NCT06590974 Org: User:
Start: 09/06/24 End: 06/30/30 Due: 06/30/31

Safety and Efficacy of Ramelteon in Elderly Subjects With Chronic Insomnia.

Phase: N/A Priority: Normal
NCT ID: NCT00671294 Org: User:
Start: 10/31/02 End: 07/31/03 Due: 07/31/04

Effect of Calcium 500 mg and Vitamin D3 1000 IU Chewable Tablet on Intestinal Calcium Absorption

Phase: N/A Priority: Normal
NCT ID: NCT02338713 Org: User:
Start: 01/31/15 End: 02/28/15 Due: 02/28/16

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of TAK-925 in Healthy Volunteers and Participants With Narcolepsy

Phase: N/A Priority: Normal
NCT ID: NCT03748979 Org: User:
Start: 11/21/18 End: 10/24/19 Due: 10/24/20

A Study of Mezagitamab in Adults With Primary Immunoglobulin A Nephropathy Receiving Stable Background Therapy

Phase: N/A Priority: Normal
NCT ID: NCT05174221 Org: User:
Start: 11/09/22 End: 03/23/26 Due: 03/23/27

Double-blind Comparative Study of TAK-875

Phase: N/A Priority: Normal
NCT ID: NCT01433393 Org: User:
Start: - End: 09/30/12 Due: 09/30/13

Single-Dose Phase 1 Study of TAK-792

Phase: N/A Priority: Normal
NCT ID: NCT02448719 Org: User:
Start: 05/27/15 End: 01/28/16 Due: 01/28/17

Drug Use Surveillance of Takecab for "Supplement to Helicobacter Pylori Eradication"

Phase: N/A Priority: Normal
NCT ID: NCT03219723 Org: User:
Start: 09/01/15 End: 04/30/17 Due: 04/30/18

A Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD)

Phase: N/A Priority: Normal
NCT ID: NCT05442567 Org: User:
Start: 05/16/23 End: 08/15/31 Due: 08/15/32

Phase 1 Single Subcutaneous Dose Study of MLN1202

Phase: N/A Priority: Normal
NCT ID: NCT02426021 Org: User:
Start: 04/30/15 End: 11/30/15 Due: 11/30/16

Namilumab vs Adalimumab in Participants With Moderate to Severe Early Rheumatoid Arthritis Inadequately Responding to Methotrexate

Phase: N/A Priority: Normal
NCT ID: NCT02393378 Org: User:
Start: 04/08/15 End: 11/16/16 Due: 11/16/17